Cargando…
Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience
The development of disease-modifying therapies for Alzheimer's disease is an urgent public health emergency. Recent failures have highlighted the significant challenges faced by drug-development programs. Longitudinal cohort studies are ideal for promoting understanding of this multifactorial,...
Autores principales: | Ritter, Aaron, Cummings, Jeffrey, Nance, Christin, Miller, Justin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118098/ https://www.ncbi.nlm.nih.gov/pubmed/30175229 http://dx.doi.org/10.1016/j.trci.2018.06.006 |
Ejemplares similares
-
Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods
por: Cummings, Jeffrey L., et al.
Publicado: (2018) -
Network-based assessment of collaborative research in neuroscience
por: Marchand, Gwen C., et al.
Publicado: (2018) -
The price of progress: Funding and financing Alzheimer's disease drug development
por: Cummings, Jeffrey, et al.
Publicado: (2018) -
Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease
por: Bluett, Brent, et al.
Publicado: (2018) -
Statistical advances in clinical trials and clinical research
por: Shan, Guogen, et al.
Publicado: (2018)